After an investigation in an adverse event, Bluebird Bio announced that it is “very unlikely” that the BB305 lentiviral vector (LVV) caused the case of acute myeloid leukemia (AML) which was reported ...
CDMO Andelyn Biosciences says that it has manufactured a viral vector with its AAV Curator ® Platform for the Nationwide Children’s Hospital’s Cellular Therapy and Cancer Immunology Program. The Adeno ...
QHP Capital (“QHP”) today announced an investment in Vector Clinical Trials (“Vector” or the “Company”), a leading clinical research site network led by Founder Dr. Bobby Mocherla. The partnership is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback